Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Exocrine Pancreas Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07235930
What this trial is testing

Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic Cancer

Who this might be right for
Non-Resectable Pancreas Carcinoma
Zhejiang Cancer Hospital 292
Post-approval studies (Phase 4)Not Yet RecruitingNCT07557394
What this trial is testing

A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 80
Testing effectiveness (Phase 2)Ended earlyNCT02985801
What this trial is testing

PERT for Treatment of Exocrine Pancreatic Insufficiency in Patients With Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic InsufficiencyPancreatic CancerPancreatic Enzyme Abnormality
Massimo Raimondo, M.D. 16
Large-scale testing (Phase 3)Study completedNCT00416507
What this trial is testing

Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Federation Francophone de Cancerologie Digestive 190
Post-approval studies (Phase 4)Ended earlyNCT03859869
What this trial is testing

Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)
AbbVie 1
Not applicableLooking for participantsNCT06651580
What this trial is testing

Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Who this might be right for
Chronic PancreatitisExocrine Pancreas CarcinomaRecurrent Acute Pancreatitis
M.D. Anderson Cancer Center 1,600
Post-approval studies (Phase 4)WithdrawnNCT01401387
What this trial is testing

Pancreatic Enzyme Suppletion in Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasNormal Pancreatic Exocrine Function
Foundation for Liver Research
Not applicableUnknownNCT04112836
What this trial is testing

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerExocrine Pancreatic InsufficiencyMetastatic Pancreatic Cancer+3 more
Moscow Clinical Scientific Center 186
Not applicableActive Not RecruitingNCT06815172
What this trial is testing

PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.

Who this might be right for
Pancreatic Adenocarcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 500
Post-approval studies (Phase 4)WithdrawnNCT04315311
What this trial is testing

Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer

Who this might be right for
Exocrine Pancreatic Insufficiency (EPI)
AbbVie
Not applicableStudy completedNCT05450627
What this trial is testing

Registry of Pancreatic Exocrine Insufficiency: Enzyme Dose Requirements and Outcomes in Pancreatic Exocrine Insufficiency Across Aetiologies

Who this might be right for
Exocrine Pancreatic Insufficiency
Hospital Clinico Universitario de Santiago 1,015
Not applicableNot Yet RecruitingNCT07365124
What this trial is testing

MRinRT: Swansea University and SWWCC Collaboration Study.

Who this might be right for
CarcinomaGlioblastomaRadiotherapy+8 more
Swansea Bay University Health Board 165
Not applicableLooking for participantsNCT04011982
What this trial is testing

PATAKESS Protocol : Clinical and Biological Analysis of Exocrine Pancreatic Tumors

Who this might be right for
Exocrine Pancreatic Cancer
Centre Leon Berard 300
Not applicableLooking for participantsNCT06422455
What this trial is testing

Access to Genetic Testing in Underserved Patients With Cancer

Who this might be right for
Breast CarcinomaMale Breast CarcinomaMalignant Solid Neoplasm+5 more
University of Southern California 800
Early research (Phase 1)Study completedNCT03517176
What this trial is testing

CEND-1 in Combination With Nabpaclitaxel and Gemcitabine in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Lisata Therapeutics, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01020006
What this trial is testing

Study of Safety and Tolerability of PCI-27483 in Patients With Pancreatic Cancer Patients Receiving Treatment With Gemcitabine

Who this might be right for
Pancreatic CancerDuctal AdrenocarcinomaExocrine Pancreatic Cancer
Pharmacyclics LLC. 42
Large-scale testing (Phase 3)Study completedNCT02172976
What this trial is testing

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Who this might be right for
Resectable Prancreas Carcinoma
Krankenhaus Nordwest 40
Post-approval studies (Phase 4)Looking for participantsNCT06099119
What this trial is testing

Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

Who this might be right for
Unresectable Pancreatic Cancer
Hospital Clinico Universitario de Santiago 100
Early research (Phase 1)Ended earlyNCT03957096
What this trial is testing

A Safety Study of SGN-CD47M in Patients With Solid Tumors

Who this might be right for
Soft Tissue SarcomaColorectal CancerHead and Neck Squamous Cell Carcinoma+6 more
Seagen Inc. 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554367
What this trial is testing

Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial

Who this might be right for
Exocrine Pancreas CarcinomaMalignant Solid NeoplasmOvarian Low Grade Serous Adenocarcinoma+2 more
National Cancer Institute (NCI) 199
Next Page